Your SlideShare is downloading. ×
0
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Eric Ittah - Consultant Neopharm Labs | Eric Ittah
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Eric Ittah - Consultant Neopharm Labs | Eric Ittah

281

Published on

Eric Ittah is a successful pharma consultant in Canada. To know more about Eric Ittah, visit www.ericittah.com …

Eric Ittah is a successful pharma consultant in Canada. To know more about Eric Ittah, visit www.ericittah.com

Published in: Technology, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
281
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. 2 Neopharm Labs Inc. - To continuously improve performance and apply technologies to serve our client partnership, while investing in competent personnel and talent, and creating a culture of pride in our work. 2
  • 2. 3  1990 – Neopharm begins operations in Blainville  1996 – Acquired by MDS Pharma Services  2006 – Warnex Acquires Neopharm from MDS ◦ Company operates 2 sites (Laval, Blainville)  2011 – Restructuring of both labs into Blainville  April 2012 – Warnex Analytical Services division sold to private investors. ◦ New name: Neopharm Labs Inc. 3
  • 3. 4  IT (DAS, infrastructure, hardware, LIMS) : $950 K  Instrument Upgrade: GC, HPLC, UPLC, Dissolution, Light Scattering : $875 K  New Service : ICP-MS : $225 K  Stability Chambers – Expansion : $250 K  Microbiology – Biolog & Others : $50 K  Total investment: $2.35 M
  • 4. 7  Inspected by the US Food and Drug Administration May 2012  Certified by Health Canada’s Health Products and Food Branch Inspectorate (HPFBI) May 2011  Controlled Drugs and substances License April 2012  Audited and qualified by many global pharmaceutical organizations
  • 5. 88  Well-established businesses since 1990  Dominant market position in Quebec  Modern facilities  FDA and HPFBI compliant  Niche in sterility testing  Large narcotics vault  Walk-in Stability Rooms Employees 135 Square Footage: •Blainville •Laval 44 000 11 000 (ex Warnex) Certificates of Analysis 1000-1500/mth HPLC’s UPLC’s 30 4 GC’s 8 AAS 2 ICP-MS 1 Dissolution Apparatus 10
  • 6. 9  Our skilled and competent Chemistry group uses a wide range of methods to test both raw materials and finished products in accordance with compendial procedures including but not limited to: USP/NF, BP, Ph.Eur, JP, FCC, ACS, AOAC, AOCS, In-house and client supplied methods
  • 7. 16  We analyze many types of samples including but not limited to: ◦ Pharmaceutical, veterinary, cosmetics ◦ Finished products: tablets, capsules, liquids, parenterals, otic and ophthalmic drops, semisolids, creams, gels, shampoos and suppositories ◦ Raw materials: actives, fillers, binders, lubricants, colours and other excipients ◦ Container/packaging components: plastics, glass, foils, bottles, strip packs and cards ◦ In-process products: bulk mixtures of solids or liquids prior to filling into capsules, bottles, vials and syringes, or before compressing into tablets
  • 8. 23  Neopharm Labs offers microbiology and sterility testing to help ensure the safety of various products and ingredients including pharmaceuticals, cosmetics, personal care products, vitamins, water, veterinary products, natural health products, etc. All analysis are performed in compliance with cGMP requirements using methods from relevant compendia and pharmacopoeia.  Our experienced microbiology team has expertise in a variety of compendial assays, including: ◦ USP/NF ◦ AAMI ◦ BP/ Ph.Eur ◦ JP ◦ AOAC ◦ AWWA ◦ FDA ◦ Client supplied methods
  • 9. 24  Antibiotic-microbial assays  Antimicrobial effectiveness testing (AET)  Microbial limits  Bioburden analysis  Desinfectant testing  Optical microscopy  Water testing  Vitamins  Bacterial endotoxin test  Methods development and validation  Particle size analysis  Microbial identification  Crystallinity  Sterility testing The following analyses are performed in compliance with cGMP requirements:
  • 10. 29  Team led by Malika Madi – 25 years experience in pharmaceutical and bioanalytical method development and validation.  Collective team experience – 60 years  HPLC – RP, NP, Ion exchange  Detection – UV, DAD, FLD, ELSD, RID, and Conductivity  GC – FID, TCD  Method dev., Method transfer, Method validation, Cleaning validation, USP verification, Forced degradation studies, Assays, Impurities, Residual solvents, Formulation stability, Reverse engineering.  Microbiology Validation Team – led by Isabelle Gladu 29
  • 11. 30  Scientific Solutions ◦ OOS Resolution ◦ Available Team for Communication  Validation  Stability Programs  Narcotic Vaults  Full Service Analytical Lab
  • 12. 31  Business Development – Eric Ittah ◦ Ext.: 364 eittah@neopharm.ca  Business Development – Marie-Josée Lachapelle ◦ Ext.: 330 mjlachapelle@neopharm.ca  Customer Service ◦ Ext.: 326, 368 sc@neopharm.ca  Director, Laboratories– Lina Iacobaccio ◦ Ext.: 363 liacobaccio@neopharm.ca  Director, Quality Assurance – Nancy Shore ◦ Ext.: 332 nshore@neopharm.ca  President and CEO– Luc Mainville ◦ Ext.: 307 lmainville@neopharm.ca 31
  • 13. 32 Neopharm Labs Inc. 865 Michele-Bohec Blainville (Quebec) J7C 5J6 www.neopharm.ca Tel: (450) 435-8864 Fax: (450) 435-7595 32

×